Ravi Shridhar, MD
Radiation Oncologist
Cancer
Overview
Dr. Shridhar is board certified in radiation oncology with special interests in improving patient care through novel clinical trial development, design of innovative radiation therapy techniques, and expanded multidisciplinary collaboration with surgical and medical oncologists. He earned both his doctorate of Pharmacology and medical degree from Wayne State University in Detroit, MI, where he also completed a radiation oncology residency at the Detroit Medical Center and Karmanos Cancer Institute. Dr. Shridhar has special expertise in the delivery of stereotactic body radiation therapy (SBRT) to lung, pancreas, liver, and adrenal primary and metastatic tumors, as well as the treatment of gastrointestinal malignancies, such as cancer of the esophagus, pancreas, rectum, gallbladder and bile ducts.Throughout his career, he has taught oncology to physicians in training, provided expert care to patients and conducted a litany of in-depth medical research and clinical trials, including more than 140 peer-reviewed publications, scientific abstracts and poster presentations. Nationally, he is on the faculty of the ASTRO E-Contouring course, teaching community radiation oncologists the complexities of treating esophageal cancer with radiation therapy. In addition, he also is an instructor for a national board review course at the Osler Institute, preparing future radiation oncologists to manage the highly complex gastrointestinal malignancies they will see in their daily practice. He is also an invited speaker at numerous national medical meetings, including the Advanced Users meeting for the treatment of liver cancers.Dr. Shridhar joined Florida Hospital Medical Group’s flagship radiation oncology practice from Moffitt Cancer Center in Tampa, where he served as Chief of Radiation Oncology GI Service and Chief of Theraspheres Radioembolization Service, as well as Associate Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. He currently maintains active positions on several national medical committees, as well as memberships in American Society for Radiation Oncology, Southwest Oncology Group and Radiation Therapy Oncology Group.
Articles
Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis
PANCREATOLOGY
2022
Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis
CANCER
2022
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2021
Comparative outcomes of transthoracic versus transhiatal esophagectomy
SURGERY
2021
Multi-agent neoadjuvant chemotherapy improves response and survival in patients with resectable pancreatic cancer
JOURNAL OF GASTROINTESTINAL ONCOLOGY
2020
Comparative outcomes of minimally invasive and robotic-assisted esophagectomy
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
2020
Strengthened capacity of India's bedaquiline Conditional Access Programme for introducing new drugs and regimens
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
2020
Comparative Perioperative Outcomes by Esophagectomy Surgical Technique
JOURNAL OF GASTROINTESTINAL SURGERY
2020
Neoadjuvant therapy and pancreatic cancer: a national cancer database analysis
JOURNAL OF GASTROINTESTINAL ONCOLOGY
2019
Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial F-18-FDG PET/CT
FRONTIERS IN ONCOLOGY
2019
Education & Training
Education
Wayne State University School of Medicine, Detroit, MI
Residency
Detroit Medical Center/Karmanos Cancer Institute, Detroit, MI
Specialty
Radiation Oncology
Board Certifications
American Board of Radiation Oncology